Butler_2021_Contemp.Clin.Trials__106488

Reference

Title : Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's - Butler_2021_Contemp.Clin.Trials__106488
Author(s) : Butler T , Goldberg JD , Galvin JE , Maloney T , Ravdin L , Glodzik L , de Leon MJ , Hochman T , Bowen RL , Atwood CS
Ref : Contemp Clin Trials , :106488 , 2021
Abstract : Butler_2021_Contemp.Clin.Trials__106488
ESTHER : Butler_2021_Contemp.Clin.Trials__106488
PubMedSearch : Butler_2021_Contemp.Clin.Trials__106488
PubMedID: 34166841

Related information

Citations formats

Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS (2021)
Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus cholinesterase inhibition to reduce neurologic decline in Alzheimer's
Contemp Clin Trials :106488

Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS (2021)
Contemp Clin Trials :106488